NSAID Rx-to-OTC guidelines
Executive Summary
Transcripts for the Feb. 22-23 meeting of the FDA Arthritis Drugs Advisory Committee, at which guidelines for nonsteroidal anti-inflammatory drug (NSAID) Rx-to-OTC switches were discussed, are now available from Dockets, the agency said. FDS invites companies to comment within two to four weeks.